Minerva Neurosciences Stock Today
| NERV Stock | USD 2.52 0.01 0.40% |
Performance0 of 100
| Odds Of DistressOver 82
|
Minerva Neurosciences is selling for under 2.52 as of the 25th of April 2024; that is -0.4 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.52. Minerva Neurosciences has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Minerva Neurosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of July 2014 | Category Healthcare | Classification Health Care |
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. The company has 6.99 M outstanding shares of which 40.31 K shares are now shorted by private and institutional investors with about 0.31 trading days to cover. More on Minerva Neurosciences
Moving against Minerva Stock
| 0.92 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.88 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.67 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.63 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.6 | BMY | Bristol Myers Squibb Earnings Call Today | PairCorr |
| 0.58 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
| 0.54 | ENVB | Enveric Biosciences Financial Report 20th of May 2024 | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 20th of May 2024
Minerva Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Minerva Neurosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Minerva Neurosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Marc Beer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Minerva Neurosciences report their recommendations after researching Minerva Neurosciences' financial statements, talking to executives and customers, or listening in on Minerva Neurosciences' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Minerva Neurosciences. The Minerva consensus assessment is calculated by taking the average forecast from all of the analysts covering Minerva Neurosciences. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Minerva Neurosciences' liquidity, profitability, solvency, and operating efficiency, Minerva Neurosciences may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Minerva Neurosciences is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Minerva Neurosciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Minerva Neurosciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Minerva Neurosciences' financial leverage. It provides some insight into what part of Minerva Neurosciences' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Minerva Neurosciences (NERV) is traded on NASDAQ Exchange in USA. It is located in 1500 District Avenue, Burlington, MA, United States, 01803 and employs 9 people. Minerva Neurosciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Minerva Neurosciences's market, we take the total number of its shares issued and multiply it by Minerva Neurosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Minerva Neurosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 6.99 M outstanding shares of which 40.31 K shares are now shorted by private and institutional investors with about 0.31 trading days to cover.
Minerva Neurosciences currently holds about 40.22 M in cash with (14.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Minerva Neurosciences Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Minerva Neurosciences is $17.69 Million. Minerva Neurosciences holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Minerva Ownership Details
Minerva Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of Minerva Neurosciences jumping above the current price in 90 days from now is about 78.78%. The Minerva Neurosciences probability density function shows the probability of Minerva Neurosciences stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Minerva Neurosciences has a beta of -0.5597. This indicates as returns on the benchmark increase, returns on holding Minerva Neurosciences are expected to decrease at a much lower rate. During a bear market, however, Minerva Neurosciences is likely to outperform the market. Additionally, minerva Neurosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Minerva Neurosciences to move above the current price in 90 days from now is about 78.78 (This Minerva Neurosciences probability density function shows the probability of Minerva Stock to fall within a particular range of prices over 90 days) .
Minerva Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Minerva Neurosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Minerva Neurosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Minerva Neurosciences' value.| Instituion | Recorded On | Shares | |
| Wells Fargo & Co | 2023-12-31 | 2 K | |
| Tower Research Capital Llc | 2023-12-31 | 1.4 K | |
| Royal Bank Of Canada | 2023-12-31 | 494 | |
| Tfc Financial Management | 2023-12-31 | 186 | |
| Bank Of America Corp | 2023-12-31 | 128 | |
| Northwestern Mutual Wealth Management Co | 2023-12-31 | 100.0 | |
| Ubs Group Ag | 2023-12-31 | 65.0 | |
| Anchor Investment Management Llc | 2023-12-31 | 12.0 | |
| Susquehanna International Group, Llp | 2023-12-31 | 0.0 | |
| Federated Hermes Inc | 2023-12-31 | 1.4 M | |
| Fmr Inc | 2023-12-31 | 491.7 K |
Minerva Neurosciences Historical Income Statement
Minerva Neurosciences Income Statement is one of the three primary financial statements used for reporting Minerva's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Minerva Neurosciences revenue and expense. Minerva Neurosciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Minerva Neurosciences' Interest Expense is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 10.9 B in 2024, whereas Operating Income is likely to drop (24.3 M) in 2024. View More FundamentalsMinerva Stock Against Markets
Picking the right benchmark for Minerva Neurosciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Minerva Neurosciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Minerva Neurosciences is critical whether you are bullish or bearish towards Minerva Neurosciences at a given time. Please also check how Minerva Neurosciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Minerva Neurosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Minerva Neurosciences Corporate Directors
Minerva Neurosciences corporate directors refer to members of a Minerva Neurosciences board of directors. The board of directors generally takes responsibility for the Minerva Neurosciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Minerva Neurosciences' board members must vote for the resolution. The Minerva Neurosciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Hans Hasler | Director | Profile | |
| Nico Vandervelpen | Director | Profile | |
| David Kupfer | Independent Director | Profile | |
| Jan Heek | Independent Director - Nominee | Profile |
How to buy Minerva Stock?
Before investing in Minerva Neurosciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Minerva Neurosciences. To buy Minerva Neurosciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Minerva Neurosciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Minerva Neurosciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Minerva Neurosciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Minerva Neurosciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Minerva Neurosciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.
Already Invested in Minerva Neurosciences?
The danger of trading Minerva Neurosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Minerva Neurosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Minerva Neurosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Minerva Neurosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Minerva Neurosciences is a strong investment it is important to analyze Minerva Neurosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Minerva Neurosciences' future performance. For an informed investment choice regarding Minerva Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Minerva Stock analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.61) | Return On Assets (0.26) | Return On Equity (6.75) |
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.